Pediatric Patients Undergoing Single-Region MRI
Conditions
Interventions
Observation group (Dexmedetomidine nasal drops combined with sevoflurane inhalation):None
Sponsors
Children's Hospital Affiliated to Shandong University
Eligibility
Sex/Gender
All
Age
No minimum to 12 Years
Inclusion criteria
Inclusion criteria: (1) American Society of Anesthesiologists (ASA) physical status classification I - II; (2) MRI examination of a single site.
Exclusion criteria
Exclusion criteria: (1) Acute respiratory tract infection or asthma attack within the past 2 weeks; (2) Body temperature exceeding 38.5°C; (3) Severe impairment of liver or kidney function; (4) Primary disease accompanied by pain; (5) History of allergy to dexmedetomidine or sevoflurane; (6) Use of other sedative-hypnotic drugs within the past 24 hours.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of the examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| The MOAA/S score of the child every 5 minutes after dexmedetomidine nasal administration;MRI examination time;Sedation time and recovery time;Vital signs at each time point;Adverse reactions during the sedation process; | — |
Countries
China
Contacts
Public ContactKong Xiangyi
Children's Hospital Affiliated to Shandong University
Outcome results
None listed